| Authors: |
Pandya T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; UKRI UCL Centre for Doctoral Training in AI-enabled Healthcare Systems, University College London, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Zagorulya M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Leung MM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK., Augustine M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Division of Medicine, University College London, London, UK., Liu LY; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Leppä AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Baruchel U; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ng SW; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Klockner T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Mugabo M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Griffen AJ; Department of Cell Biology, Albert Einstein College of Medicine, Montefiore Health System, Bronx, New York, NY, USA; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York, NY, USA., Blyuss O; Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK; Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Iliakis CS; Immunoregulation Laboratory, The Francis Crick Institute, London, UK., Grenov A; Autoimmunity Laboratory, The Francis Crick Institute, London, UK., Haase K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Muller DC; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., Chan KH; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Oxford Global Health, University of Oxford, Oxford, UK., Wu J; Novartis, Cambridge, MA, USA., Burk VA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Wright N; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Le Marois A; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Pazukhina E; Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Genomics Science Technology Platform, The Francis Crick Institute, London, UK., Slawinski H; Genomics Science Technology Platform, The Francis Crick Institute, London, UK., Pelletier M; Novartis, Cambridge, MA, USA., Murphy C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Park MD; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Snoeks T; Imaging Research Facility, The Francis Crick Institute, London, UK., Suarez-Bonnet A; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK; Experimental Histopathology, The Francis Crick Institute, London, UK., Priestnall SL; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK; Experimental Histopathology, The Francis Crick Institute, London, UK., Chardas A; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK., Grieco C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Archer A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Celik A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Jimenez-Sanchez A; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scott R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Zahed H; Early Detection, Prevention and Infections Branch (EPR), International Agency for Research on Cancer (IARC/WHO), Lyon, France., Montégut L; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Meza R; Department of Population Health Sciences, British Columbia Cancer Research Institute, Vancouver, BC, Canada., Durney CH; Department of Population Health Sciences, British Columbia Cancer Research Institute, Vancouver, BC, Canada., Lam S; Department of Basic and Translational Research, British Columbia Cancer Research Institute, Vancouver, BC, Canada., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Thoracic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Vermeulen RCH; Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands., Xu H; Novartis Biomedical Research, Cambridge, MA, USA., Serrano-Fernandez P; Novartis Pharmaceuticals, Basel, Switzerland., Crnogorac-Jurcevic T; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK., Menon U; UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Apostolidou S; UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Zaikin A; Department of Mathematics and Institute for Women's Health, University College London, London, UK; Centre for Cognition and Decision making, Institute for Cognitive Neuroscience, HSE University, Moscow, Russia., Gunu R; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK., Whitwell HJ; National Phenome Centre and Imperial Clinical Phenotyping Centre, Department of Metabolism, Digestion and Reproduction, IRDB, Imperial College London, London, UK; Section of Bioanalytical Chemistry, Burlington Danes Building, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Huang Z; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Li Z; Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK., Hu X; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhu B; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li L; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China; Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China., Chirlaque MD; Department of Epidemiology, Regional Health Council, Murcia University, Murcia, Spain; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Biomedical Research Institute of Murcia Pascual Parrilla-IMIB, 30120 Murcia, Spain., Guevara M; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Instituto de Salud Pública y Laboral de Navarra, 31003 Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain., Kolijn PM; Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands., Guenoun A; Early Detection, Prevention and Infections Branch (EPR), International Agency for Research on Cancer (IARC/WHO), Lyon, France., Mookherjee N; Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada., Johansson M; Early Detection, Prevention and Infections Branch (EPR), International Agency for Research on Cancer (IARC/WHO), Lyon, France., Wang Z; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Chatterjee N; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Chiu CH; Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan., Chen Z; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Howard Hughes Medical Institute, New York, NY, USA., Sahai E; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK., Freytag S; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia., Wack A; Immunoregulation Laboratory, The Francis Crick Institute, London, UK., Gunter MJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; Cancer Epidemiology and Prevention Research Unit, School of Public Health, Imperial College London, London, UK., Merad M; Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Zhang J; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carlsten C; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department of Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada., Yang PC; National Taiwan University YongLin Institute of Health, National Taiwan University, Taipei 106, Taiwan; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei 100, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan., Chen HY; Institute of Statistical Science, Academia Sinica, Taipei 115, Taiwan., Platz EA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., LaFave LM; Department of Cell Biology, Albert Einstein College of Medicine, Montefiore Health System, Bronx, New York, NY, USA; Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York, NY, USA., Smith-Byrne K; Cancer Epidemiology Unit, University of Oxford, Oxford OX3 7LF UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK., Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Nene NR; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Hill W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. Electronic address: william.hill@cruk.manchester.ac.uk., Weeden CE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. Electronic address: weeden.c@wehi.edu.au., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK. Electronic address: charles.swanton@crick.ac.uk. |
